POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,746 | +40.3% | 91,490 | +3.8% | 0.00% | – |
| Q2 2023 | $155,179 | -92.3% | 88,170 | -86.5% | 0.00% | – |
| Q1 2023 | $2,006,294 | +39.2% | 651,394 | +139.5% | 0.00% | – |
| Q4 2022 | $1,441,473 | +88.2% | 271,976 | +25.3% | 0.00% | – |
| Q3 2022 | $766,000 | +233.0% | 217,001 | +543.4% | 0.00% | – |
| Q4 2021 | $230,000 | +75.6% | 33,726 | +87.4% | 0.00% | – |
| Q3 2021 | $131,000 | -14.4% | 18,000 | +17.6% | 0.00% | – |
| Q2 2021 | $153,000 | -67.0% | 15,300 | -68.4% | 0.00% | – |
| Q1 2021 | $463,000 | – | 48,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $10,454,000 | 1.67% |
| Boxer Capital, LLC | 1,251,055 | $12,536,000 | 0.44% |
| Pentwater Capital Management LP | 4,967,227 | $49,772,000 | 0.41% |
| KNOTT DAVID M | 29,566 | $296,000 | 0.10% |
| Perceptive Advisors | 1,575,490 | $15,786,000 | 0.10% |
| Virtus ETF Advisers LLC | 24,287 | $243,000 | 0.10% |
| Advisory Services Network, LLC | 256,772 | $2,573,000 | 0.08% |
| J. Goldman & Co LP | 202,501 | $2,029,000 | 0.08% |
| Ikarian Capital, LLC | 85,837 | $861,000 | 0.07% |
| Regent Investment Management LLC | 25,000 | $251,000 | 0.06% |